Free Trial

Baxter International (BAX) Competitors

Baxter International logo
$33.04 -0.56 (-1.67%)
Closing price 03/25/2025 03:58 PM Eastern
Extended Trading
$33.10 +0.06 (+0.18%)
As of 03/25/2025 05:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BAX vs. BDX, EW, IDXX, RMD, DXCM, STE, PODD, HOLX, GMED, and MASI

Should you be buying Baxter International stock or one of its competitors? The main competitors of Baxter International include Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), Hologic (HOLX), Globus Medical (GMED), and Masimo (MASI). These companies are all part of the "health care equipment" industry.

Baxter International vs.

Baxter International (NYSE:BAX) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, community ranking, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership.

Baxter International pays an annual dividend of $0.68 per share and has a dividend yield of 2.1%. Becton, Dickinson and Company pays an annual dividend of $4.16 per share and has a dividend yield of 1.8%. Baxter International pays out -53.1% of its earnings in the form of a dividend. Becton, Dickinson and Company pays out 69.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Becton, Dickinson and Company has increased its dividend for 53 consecutive years. Baxter International is clearly the better dividend stock, given its higher yield and lower payout ratio.

90.2% of Baxter International shares are held by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are held by institutional investors. 0.2% of Baxter International shares are held by company insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Baxter International received 136 more outperform votes than Becton, Dickinson and Company when rated by MarketBeat users. Likewise, 65.69% of users gave Baxter International an outperform vote while only 62.41% of users gave Becton, Dickinson and Company an outperform vote.

CompanyUnderperformOutperform
Baxter InternationalOutperform Votes
737
65.69%
Underperform Votes
385
34.31%
Becton, Dickinson and CompanyOutperform Votes
601
62.41%
Underperform Votes
362
37.59%

In the previous week, Becton, Dickinson and Company had 34 more articles in the media than Baxter International. MarketBeat recorded 39 mentions for Becton, Dickinson and Company and 5 mentions for Baxter International. Becton, Dickinson and Company's average media sentiment score of 1.30 beat Baxter International's score of 0.10 indicating that Becton, Dickinson and Company is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Baxter International
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Becton, Dickinson and Company
31 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Becton, Dickinson and Company has higher revenue and earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baxter International$10.64B1.59-$649M-$1.28-25.81
Becton, Dickinson and Company$20.64B3.17$1.71B$6.0237.87

Baxter International currently has a consensus price target of $38.56, indicating a potential upside of 16.69%. Becton, Dickinson and Company has a consensus price target of $278.29, indicating a potential upside of 22.08%. Given Becton, Dickinson and Company's stronger consensus rating and higher possible upside, analysts plainly believe Becton, Dickinson and Company is more favorable than Baxter International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Baxter International
1 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.40
Becton, Dickinson and Company
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00

Baxter International has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Comparatively, Becton, Dickinson and Company has a beta of 0.35, meaning that its stock price is 65% less volatile than the S&P 500.

Becton, Dickinson and Company has a net margin of 8.47% compared to Baxter International's net margin of -5.05%. Baxter International's return on equity of 16.67% beat Becton, Dickinson and Company's return on equity.

Company Net Margins Return on Equity Return on Assets
Baxter International-5.05% 16.67% 4.93%
Becton, Dickinson and Company 8.47%15.74%7.29%

Summary

Becton, Dickinson and Company beats Baxter International on 14 of the 21 factors compared between the two stocks.

Remove Ads
Get Baxter International News Delivered to You Automatically

Sign up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BAX vs. The Competition

MetricBaxter InternationalSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$16.90B$4.45B$5.67B$19.75B
Dividend Yield2.03%32.62%4.55%3.75%
P/E Ratio-25.8128.8524.5934.06
Price / Sales1.5950.39395.6328.49
Price / Cash6.4551.0838.1617.54
Price / Book1.986.267.054.63
Net Income-$649M$67.64M$3.20B$1.02B
7 Day Performance-4.22%9.92%1.42%1.17%
1 Month Performance-8.22%-1.05%5.77%-1.04%
1 Year Performance-20.94%24.78%14.93%7.12%

Baxter International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BAX
Baxter International
4.0161 of 5 stars
$33.04
-1.7%
$38.56
+16.7%
-20.9%$16.90B$10.64B-25.8160,000
BDX
Becton, Dickinson and Company
4.8472 of 5 stars
$227.95
+0.9%
$278.29
+22.1%
-5.7%$65.43B$20.64B37.8574,000Analyst Downgrade
Options Volume
Positive News
EW
Edwards Lifesciences
4.8304 of 5 stars
$70.91
+2.3%
$79.95
+12.8%
-23.5%$41.69B$5.44B10.1717,300Positive News
IDXX
IDEXX Laboratories
4.2637 of 5 stars
$422.60
+1.8%
$533.75
+26.3%
-21.2%$34.37B$3.90B39.6110,800Analyst Downgrade
Positive News
RMD
ResMed
4.7776 of 5 stars
$225.61
+0.6%
$243.82
+8.1%
+14.5%$33.14B$4.93B26.648,160Analyst Upgrade
Positive News
DXCM
DexCom
4.8896 of 5 stars
$71.93
+1.8%
$99.82
+38.8%
-47.5%$28.15B$4.03B50.377,600Positive News
STE
STERIS
4.5339 of 5 stars
$228.28
+0.7%
$258.75
+13.3%
+0.5%$22.44B$5.40B48.5018,179Positive News
PODD
Insulet
3.9969 of 5 stars
$262.04
+2.6%
$292.06
+11.5%
+65.5%$18.43B$2.07B45.333,000Positive News
HOLX
Hologic
4.9444 of 5 stars
$61.58
+1.4%
$84.62
+37.4%
-19.6%$13.83B$4.04B19.447,063Analyst Revision
GMED
Globus Medical
4.8691 of 5 stars
$72.42
+1.9%
$97.82
+35.1%
+49.9%$9.96B$2.52B96.535,000
MASI
Masimo
3.8047 of 5 stars
$172.06
+2.3%
$194.80
+13.2%
+21.7%$9.30B$2.09B118.846,200Positive News
Remove Ads

Related Companies and Tools


This page (NYSE:BAX) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners